Search - tctmd.com

Displaying 101 - 120 of 229

Sort: Relevancy | Date

News Conference News VIVA 2019

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

L.A. McKeown

November 08, 2019

News Daily News

Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD

Todd Neale

October 29, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Yael L. Maxwell

October 16, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Todd Neale

September 02, 2019

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

News Daily News

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

Michael O'Riordan

May 02, 2019

News Daily News

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Michael O'Riordan

April 15, 2019

News Opinion Fellow Talk

Public Reporting and the Budding Interventional Cardiologist

Yashasvi Chugh, MD

March 28, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

News Daily News

Direct Admission to PCI-Capable Center Linked With Lower All-Cause Mortality

Michael O'Riordan

March 06, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

Advertisement

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

TCTMD’s Top 10 Most Popular Stories for June 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Public Reporting and the Budding Interventional Cardiologist

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Direct Admission to PCI-Capable Center Linked With Lower All-Cause Mortality

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content